Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance

To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized in double blind fashion to placebo or pioglitazone for diabetes prevention in the ACT NOW stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinoza, Sara E., Wang, Chen-pin, Tripathy, Devjit, Clement, Stephen C., Schwenke, Dawn C., Banerji, Mary Ann, Bray, George A., Buchanan, Thomas A., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Stentz, Frankie B., Reaven, Peter D., DeFronzo, Ralph A., Musi, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266219/
https://www.ncbi.nlm.nih.gov/pubmed/27585671
http://dx.doi.org/10.1007/s11357-016-9946-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266219/
https://www.ncbi.nlm.nih.gov/pubmed/27585671
http://dx.doi.org/10.1007/s11357-016-9946-6

Ejemplares similares